Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.
about
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileContinuous Glucose Monitoring: A Review of Successes, Challenges, and OpportunitiesDevelopment of the Likelihood of Low Glucose (LLG) algorithm for evaluating risk of hypoglycemia: a new approach for using continuous glucose data to guide therapeutic decision makingThe Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.New approaches to display of self-monitoring of blood glucose dataMetrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study.Diet and glycaemia: the markers and their meaning. A report of the Unilever Nutrition Workshop.Design of a decision support system to help clinicians manage glycemia in patients with type 2 diabetes mellitus.Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literatureDifferences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects.Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c.Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 DiabetesGlucose Variability: Comparison of Different Indices During Continuous Glucose Monitoring in Diabetic PatientsReference values for continuous glucose monitoring in Chinese subjects.First Clinical Experience with Retrospective Flash Glucose Monitoring (FGM) Analysis in South Africa: Characterizing Glycemic Control with Ambulatory Glucose Profile.Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?Effective assessment of diabetes control using personal glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA).Use of technology when assessing adherence to diabetes self-management behaviors.DPP-4 inhibitors: pharmacological differences and their clinical implications.Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes.Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.Diurnal glucose exposure profiles of patients treated with lixisenatide before breakfast or the main meal of the day: An analysis using continuous glucose monitoring.Ambulatory glucose profile analysis of the juvenile diabetes research foundation continuous glucose monitoring dataset-Applications to the pediatric diabetes population.Pharmacodynamic model of sodium-glucose transporter 2 (SGLT2) inhibition: implications for quantitative translational pharmacology.Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.Impact of Carbohydrate Content and Glycemic Load on Postprandial Glucose After Roux-en-Y Gastric Bypass.Evaluating quality of glycemic control: graphical displays of hypo- and hyperglycemia, time in target range, and mean glucoseDisplay of glucose distributions by date, time of day, and day of week: new and improved methods.Point: postprandial glucose levels are a clinically important treatment target.International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece.Postprandial hyperglycemia and cardiovascular disease: is the HEART2D study the answer?Increased mean glucose levels in patients with polycystic ovary syndrome and hyperandrogenemia as determined by continuous glucose monitoring.Nocturnal hypoglycaemia in ACTH and GH deficient children: role of continuous glucose monitoring.Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures.Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, thRelationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetes.Greater low-density lipoprotein cholesterol variability is associated with increased progression to dialysis in patients with chronic kidney disease stage 3.
P2860
Q27687563-F94ADF39-74C4-4372-9DA5-A4CB9469CF21Q28076888-5F7BA5FC-1F9A-4764-92EE-9ED946E6C649Q30827647-BFD92A4F-C28F-448A-8AED-25D5CD4C44D3Q30985130-5EDC71C7-0C41-4C5E-B260-D9FC610D3B79Q33530416-6D2B7AD6-624A-44E8-8952-7A505203DD99Q33727475-16C3D681-76D6-4739-A917-7A619EBE3FB2Q33786175-5C16FC0D-23A8-4919-AF34-EC9196648E94Q33940824-CE4E9080-600D-4F1D-93F4-B5A3BE75EC1BQ34997385-4F1BDC7A-39CC-4081-B8BD-3157C1F62A3EQ35076025-620F0136-1E65-4854-9765-A8514AD20A82Q35177261-C7C8067A-1FE7-447C-8832-9C7B1540EBE2Q35682645-5C5D11CC-6287-44A1-9A02-EE753ECF5F0FQ35682721-351BDB02-3BC9-4AEA-A7A9-059FCB67C205Q35684670-5CBAA54F-9019-41F2-BD16-23A6507CF49EQ36257199-29A55F7D-F16F-4C62-9463-D286D7F24CA7Q37054676-BC5A8B40-E502-4927-892C-6AD07D52245FQ37235844-75AF266A-FFCA-48E7-B2F9-D1BF3E982490Q37391391-926040F3-6281-4D56-B68E-E1E682D0D26CQ37404282-0B64229A-211D-4226-9808-396A1E8FCAE5Q37433075-6205794A-AF0F-4D7D-ACAE-40269994854BQ38229366-E480CD2E-FA92-49FB-9483-52948F5C9C5FQ38244576-AD9B01DD-2498-4DB5-A845-7CCE77C995C4Q38679404-3C3A5EE0-433F-45D2-9E9E-74E7A734A52DQ38771704-EA31C488-A80F-45E0-AE7F-60F7F3A4293BQ39054666-7C34E4D6-1931-4D71-AAE3-661548A012CFQ39159963-E7A28178-E8D7-4D12-BA63-E138290BE7CEQ39636097-FC221D0C-9587-42F0-A69F-D08440C195ECQ40232094-FCB06854-EB38-49BA-8615-B4BF8F4CD62CQ41225082-494BAD70-4FC6-4B1F-BF12-6939E2BF6143Q41236984-A1A68F9D-34A4-448B-99DB-FE3AE84E5B69Q42691654-A407F34C-E82C-4529-B909-C1D608F5D0ACQ42707636-B04CBA1C-8DDD-4A62-B2D6-7A2131516563Q42730182-F9E1EBAA-0219-46DE-A665-E8D44CFBE916Q43177184-5EA47E8C-8FF7-4179-A2BB-1CF3E86D9343Q44578117-0ADD2F93-3881-493E-9EDB-EBED92977EB7Q46883016-81041B6D-0CCE-4F9B-8FA4-C810CE4E071BQ47200528-4A58F086-A70E-4250-BB49-B0FF4B9CDED2Q47825623-3AFFE651-C909-416E-8043-FEDEA7BAC6CAQ49110588-5AEEF7F5-F1DC-4584-B938-88B615023DBDQ49588056-148825F2-E32F-4AE9-A004-1252D0869FB2
P2860
Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Characterizing glucose exposur ...... tory glucose profile analysis.
@en
Characterizing glucose exposur ...... tory glucose profile analysis.
@nl
type
label
Characterizing glucose exposur ...... tory glucose profile analysis.
@en
Characterizing glucose exposur ...... tory glucose profile analysis.
@nl
prefLabel
Characterizing glucose exposur ...... tory glucose profile analysis.
@en
Characterizing glucose exposur ...... tory glucose profile analysis.
@nl
P2093
P921
P356
P1476
Characterizing glucose exposur ...... tory glucose profile analysis.
@en
P2093
Blaine Morgan
David Wesley
Ellie Strock
Richard Bergenstal
Robert Cuddihy
Roger S Mazze
Sarah Borgman
P304
P356
10.1089/DIA.2007.0293
P577
2008-06-01T00:00:00Z